Literature DB >> 2671792

When did Lou Gehrig's personal illness begin?

E J Kasarskis1, M Winslow.   

Abstract

Mesh：

Year:  1989        PMID： 2671792     DOI： 10.1212/wnl.39.9.1243

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Motor neuron disease.

Authors:  M Swash
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  Energy intake and amyotrophic lateral sclerosis.

Authors:  Mark P Mattson; Roy G Cutler; Simonetta Camandola
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 3.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

4.  Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS.

Authors:  Yuri Ciervo; Noemi Gatto; Chloe Allen; Andrew Grierson; Laura Ferraiuolo; Richard J Mead; Pamela J Shaw
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-27       Impact factor: 6.698

Review 5.  Mitochondrial degeneration in amyotrophic lateral sclerosis.

Authors:  Zuoshang Xu; Cheowha Jung; Cynthia Higgins; John Levine; Jiming Kong
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

6.  Decline in daily running distance presages disease onset in a mouse model of ALS.

Authors:  Daniel A Bruestle; Roy G Cutler; Richard S Telljohann; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-05-06       Impact factor: 3.843
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.